They’ll tell you how often you’ll need follow-up bone density tests. Your provider might suggest weight-bearing exercise to strengthen your muscles and train your balance. Staying active can strengthen your bones. The most important part of treating osteoporosis is preventing broken bones. Providers sometimes refer to bone density tests as DEXA scans, DXA scans or bone density scans. People in postmenopause lose bone mass even faster. This causes a gradual loss of bone mass.
Baseline extension torque was measured at 2 weeks before surgery and normalized to 0. At 12 and 24 weeks postoperatively, there were no significant between-group differences in LH and FSH levels. Eight patients received an autograft for ACL reconstruction (6 hamstring, 2 bone–patellar tendon–bone), while 5 patients were repaired using allografts (4 semitendinosus, 1 bone–patellar tendon–bone). Of the 13 patients enrolled in the study, 6 underwent repair for meniscal tears. An a priori power analysis was performed using nQuery Version 4 (Stasols) to estimate the number of participants needed to find a statistically significant difference in lean mass. The TAS was also administered at each study visit to determine preinjury physical activity levels.
Line plot of the change in lean mass from baseline at 1 day before surgery and 6, 12, and 24 weeks after surgery. There were no statistically significant baseline differences in lean mass or leg strength between the groups. Preliminary data were taken from a study that found a change in lean mass of 3.0 ± 1.5 kg in healthy men receiving testosterone.46 Using a significance level of 0.05 and a power of 0.80, a sample size of 6 participants per group was calculated to observe similar effects. The primary outcome was the change in total lean body mass from baseline, while secondary outcomes included muscle strength and the Knee injury and Osteoarthritis Outcome Score (KOOS). This is the first study to investigate the effect of testosterone on lean mass after ACL reconstruction in young, healthy, eugonadal male patients. Future clinical studies should aim to collect more detailed data on TRT usage, including the dosage, duration, timing relative to surgery, and the specific form of administration, to better assess its impact on surgical outcomes.
All 4 studies showed significant improvements in functional independence, BMD, muscle volume in the operative and nonoperative leg, Harris hip score, gait speed, Katz score, lean body mass, and strength. Prior studies of perioperative testosterone supplementation have used 600 mg/wk of testosterone enanthate for 4 weeks and 600 mg/wk for 10 weeks.2,7 The goal in dosing was to elevate testosterone levels in the testosterone group to approximately 1000 to 1200 ng/dL; however, serum levels reached a peak mean value of 860 ng/dL. This may in part be because of the baseline difference in injured leg strength between the 2 study groups, which approached significance. Line plot of the change in peak extension torque of the injured leg from baseline to 1 day before surgery and 6, 12, and 24 weeks after surgery. Effect of testosterone on the change in strength of the injured leg from baseline. Line plot of the change in peak extension torque of the uninjured leg from baseline to 1 day before surgery and 6, 12, and 24 weeks after surgery.
This study queried the database in order to identify the patient cohorts, including patients undergoing RSA, and those that received TRT. To our knowledge, there are no current studies that investigate the effect of TRT on patients undergoing RSA. One study demonstrated an increased risk of prosthetic joint infection following any form of total shoulder arthroplasty (TSA) in patients who were on TRT . While there is established research on the basic science of the musculoskeletal system, there remains a paucity of literature on the effect of TRT on the clinical outcomes of orthopedic shoulder surgeries . Given the prevalence of transgender individuals who may be on TRT during the perioperative period of an orthopedic procedure, understanding the proper management of these patients is important.
You can prevent bone density loss with treatments and exercise. The relation between testosterone replacement therapy (TRT) and anterior cruciate ligament injury risk has garnered attention in recent orthopaedic research. Your provider will discuss your health history with you along with the results from your tests to determine if you could benefit from testosterone therapy. You can start therapy as soon as your blood tests come back with evidence of low testosterone and your provider has determined you are a good candidate for treatment. Your provider will order additional tests to help determine the cause of your low testosterone levels and rule out any underlying health issues that could affect (or prevent) your treatment.

Gender: Female

Social links